Loading
ACannabis 2020 - Medicinal cannabis - scientist
3 - 4 March, 2020
Melbourne
Tickets on sale now
Scroll

What is ACannabis?

ACannabis is the platform to gain a deep understanding of ground-breaking research, an inside perspective on global trends and a unique opportunity for the agritech and medtech sector to have the conversations required to leverage our advantages.

FUTURE

Our Speakers

VIEW PROFILE
Prof. Jonathan Cebon
Programme Lead - Cancer Immunobiology, Olivia Newton-John Cancer Research Institute
VIEW PROFILE
Rodney Cocks
Chief Executive Officer & Director, Cronos Australia
VIEW PROFILE
Rhys Cohen
Principal Consultant, FreshLeaf Analytics
VIEW PROFILE
Peter Crock
CEO - Cann Group, Chair - Medicinal Cannabis Industry Australia
VIEW PROFILE
Elisabetta Faenza
CEO and Co-Founder, LeafCann Group
VIEW PROFILE
Thomas Forrest CF
Agronomist, Indicated Technology
VIEW PROFILE
Russell Harding
Executive Chairman & CEO, MedReleaf Australia
See All Speakers

Tickets

All tickets are for 1.​5 days and include: Access to all elements of the event (including exhibition hub and all sessions), morning / afternoon tea and lunch catering as well as food, beverages and entertainment at the networking event at the conclusion of Day 1 formalities.

Click here to read the terms and conditions associated with all ticket purchases.
*Please note that a processing fee is applicable when completing the registration through eventbrite.
Delegate Registration
$825*
On sale until 5:​00pm AEDT
2 March 2020. $825 incl. GST*
Get Tickets

Founding Partners

See more
Become a Partner!

Interested in becoming a partner of ACannabis? Download our Partnership and Exhibition Prospectus or contact us for a tailored solution to meet your needs.

Download

Why is ACannabis Different?

ACannabis is different to other events currently happening across Australia because it will:

  • Increase the capability of the Australian ecosystem
  • Build a productive bridge between research and industry
  • Accelerate the reputation of being a clean green medicinal supplier
  • Position Australia as an active player in the international medicinal cannabis ecosystem
  • Encourage investment into the wellbeing of patients
  • Create a platform for patient advocates to be heard
  • An opportunity to establish patient focused policies
  • Create one location to see what is happening across the medicinal cannabis industry
Join Us!

Register your interest to attend and stay up to date with our latest news.

Register